We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+53.66%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$698M
Cap. Flow
+$418M
Cap. Flow %
28.92%
Top 10 Hldgs %
21.33%
Holding
759
New
418
Increased
75
Reduced
55
Closed
163

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16.2M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$4.48M
3
ZM icon
Zoom
ZM
+$3.15M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$2.84M
5
LYFT icon
Lyft
LYFT
+$2.67M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.12%
2 Healthcare 2.1%
3 Technology 1.03%
4 Industrials 0.75%
5 Financials 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBT icon
351
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$636K 0.04%
+40,000
New +$640K
ZYNE
352
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$623K 0.04%
+185,000
New +$875K
RGLD icon
353
PUT
Royal Gold
RGLD
$16.6B
$622K 0.04%
+5,000
New +$604K
UBER icon
354
PUT
Uber
UBER
$145B
$622K 0.04%
20,000
WORK
355
PUT
DELISTED
Slack Technologies, Inc.
WORK
$622K 0.04%
+20,000
New +$601K
ZEN
356
DELISTED
ZENDESK INC
ZEN
$620K 0.04%
+7,000
New +$539K
PAM icon
357
CALL
Pampa Energía
PAM
$4.57B
$619K 0.04%
+59,000
New +$627K
MS icon
358
CALL
Morgan Stanley
MS
$319B
$618K 0.04%
+12,800
New +$538K
OMC icon
359
CALL
Omnicom Group
OMC
$23.5B
$617K 0.04%
11,300
-300
-3% -$16.3K
STAA icon
360
PUT
STAAR Surgical
STAA
$1.19B
$615K 0.04%
+10,000
New +$408K
GWPH
361
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$614K 0.04%
+5,000
New +$567K
EFA icon
362
iShares MSCI EAFE ETF
EFA
$76.4B
$609K 0.04%
+10,000
New +$578K
PRU icon
363
Prudential Financial
PRU
$42.6B
$609K 0.04%
+10,000
New +$587K
TCO
364
DELISTED
Taubman Centers Inc.
TCO
$604K 0.04%
+16,000
New +$654K
GOTU icon
365
CALL
Gaotu Techedu
GOTU
$405M
$600K 0.04%
+10,000
New +$396K
INTU icon
366
CALL
Intuit
INTU
$91.1B
$592K 0.04%
+2,000
New +$549K
UNH icon
367
UnitedHealth
UNH
$382B
$590K 0.04%
+2,000
New +$573K
SBRA icon
368
CALL
Sabra Healthcare REIT
SBRA
$5.56B
$577K 0.04%
+40,000
New +$526K
VICR icon
369
Vicor
VICR
$8.33B
$576K 0.04%
+8,000
New +$449K
TREB.U
370
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$575K 0.04%
+55,000
New +$572K
AUPH icon
371
Aurinia Pharmaceuticals
AUPH
$1.95B
$569K 0.04%
+35,000
New +$560K
INO icon
372
PUT
Inovio Pharmaceuticals
INO
$85.6M
$566K 0.04%
+1,750
New +$281K
CGC
373
CALL
Canopy Growth
CGC
$376M
$559K 0.04%
+3,460
New +$560K
DHI icon
374
CALL
D.R. Horton
DHI
$41.2B
$555K 0.04%
+10,000
New +$485K
DMLP icon
375
PUT
Dorchester Minerals
DMLP
$1.3B
$552K 0.04%
+43,200
New +$491K

Similar funds

SG3 Management's Q2 2020 Portfolio in Review

As of Q2 2020, SG3 Management held 759 positions worth $1.45B, up 93% from $748M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management deployed $418M of net new capital in Q2 2020, opening 418 new positions and adding to 75 existing holdings. Its largest new stake was Sea Limited: 183,000 shares worth $19.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.1% of assets, up from 2% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.21M trimmed.

  • SG3 Management's largest Q2 2020 buy was Sea Limited: 183,000 shares worth $19.6M.
  • SG3 Management added most to PENN Entertainment in Q2 2020, an estimated $2.45M increase.
  • SG3 Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.21M.
  • SG3 Management fully exited Tesla in Q2 2020, selling an estimated $16.2M.
  • SG3 Management's ten largest holdings make up 21% of its $1.45B portfolio in Q2 2020.
  • SG3 Management opened 418 new positions and closed 163 in Q2 2020.
  • SG3 Management's portfolio value rose 93% quarter-over-quarter to $1.45B.

Based on SG3 Management's 13F filing for Q2 2020, filed 14 Aug 2020.